Get started
RAPT Therapeutics, Inc.RAPT Therapeutics, Inc.RAPT Therapeutics, Inc.

RAPT Therapeutics, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options

RAPT chart


Full chart

RAPT upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪104.35 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−3.1162 USD
Net income (FY)
‪−129.87 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪68.90 M‬
Beta (1Y)
1.42

Employees


Employees (FY)
68
Change (1Y)
−63 −48.09%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−1.91 M‬ USD

About RAPT Therapeutics, Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Brian Russell Wong
Website
rapt.com
Headquarters
South San Francisco
Founded
2015
FIGI
BBG00PGK50M2
Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company, which engages in the discovery, development, and commercialization of oral small molecule therapies for patients in oncology and inflammatory diseases. The company was founded in 2015 and is headquartered in South San Francisco, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

RAPT news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as RAPT.

Frequently Asked Questions


The current price of RAPT is 0.7905 USD — it has decreased by −1.32% in the past 24 hours. Watch RAPT Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange RAPT Therapeutics, Inc. stocks are traded under the ticker RAPT.
RAPT stock has fallen by −12.17% compared to the previous week, the month change is a −29.42% fall, over the last year RAPT Therapeutics, Inc. has showed a −90.32% decrease.
We've gathered analysts' opinions on RAPT Therapeutics, Inc. future price: according to them, RAPT price has a max estimate of 10.00 USD and a min estimate of 2.00 USD. Watch RAPT chart and read a more detailed RAPT Therapeutics, Inc. stock forecast: see what analysts think of RAPT Therapeutics, Inc. and suggest that you do with its stocks.
RAPT reached its all-time high on Jan 28, 2020 with the price of 51.2095 USD, and its all-time low was 0.7534 USD and was reached on Apr 17, 2025. View more price dynamics on RAPT chart.
See other stocks reaching their highest and lowest prices.
RAPT stock is 14.06% volatile and has beta coefficient of 1.42. Track RAPT Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is RAPT Therapeutics, Inc. there?
Today RAPT Therapeutics, Inc. has the market capitalization of ‪104.35 M‬, it has decreased by −3.59% over the last week.
Yes, you can track RAPT Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
RAPT Therapeutics, Inc. is going to release the next earnings report on May 8, 2025. Keep track of upcoming events with our Earnings Calendar.
RAPT earnings for the last quarter are −1.14 USD per share, whereas the estimation was −0.32 USD resulting in a −257.02% surprise. The estimated earnings for the next quarter are −0.14 USD per share. See more details about RAPT Therapeutics, Inc. earnings.
RAPT Therapeutics, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
RAPT net income for the last quarter is ‪−53.25 M‬ USD, while the quarter before that showed ‪−18.43 M‬ USD of net income which accounts for −188.89% change. Track more RAPT Therapeutics, Inc. financial stats to get the full picture.
No, RAPT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 21, 2025, the company has 68 employees. See our rating of the largest employees — is RAPT Therapeutics, Inc. on this list?
Like other stocks, RAPT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RAPT Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RAPT Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RAPT Therapeutics, Inc. stock shows the sell signal. See more of RAPT Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.